FA
ELV icon

Friess Associates’s Elevance Health ELV Stock Holding History

Friess Associates’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-76,235
Closed -$20.9M – 127
2018
Q3 		$20.9M Sell
76,235
-1,870
-2% -$485K 1.46% 24
2018
Q2 		$18.6M Buy
+78,105
New +$18.1M 1.47% 29

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Friess Associates's ELV Position: Q4 2018 in Review

Friess Associates sold out of Elevance Health (ELV) in Q4 2018, closing a stake of 76,235 shares — an estimated $20.9M sold.

Friess Associates first reported a position in ELV in Q2 2018 and held it in 2 quarters. The position peaked at $20.9M in Q3 2018. 997 funds tracked by Wall St. Rank hold ELV as of Q4 2018.

  • Friess Associates reported no remaining Elevance Health position as of Q4 2018 after selling out during the quarter.
  • Friess Associates sold 76,235 Elevance Health shares in Q4 2018, an estimated $20.9M.
  • Friess Associates first reported a position in Elevance Health in Q2 2018 and held it in 2 quarters.
  • Friess Associates's Elevance Health position peaked at $20.9M in Q3 2018.
  • 997 funds tracked by Wall St. Rank held Elevance Health as of Q4 2018.

Based on Friess Associates's 13F filing for Q4 2018, filed 14 Feb 2019.